Louisiana Board of Pharmacy - State of Louisiana

Print RSS Share This Site
photo-pharmacist State of Louisiana


Pharmaceutical Cost Transparency

Act 220 of 2017 Legislature

Sunday, October 1, 2017

Act 220 of the 2017 Legislature requires drug manufacturers marketing their drugs to Louisiana to report wholesale acquisition cost information to the Board on a quarterly basis.  Until the Board has developed the web portal which manufacturers will use to report their information, the Board has established a reporting procedure for the interim reports.  The Pharmaceutical Cost Transparency document is available here as well as in the Guidance Documents section in the Public Library.